- Home
- PGEN vs QSI Comparison
PGEN vs QSI Comparison
Compare PGEN & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- QSI
- Stock Information
- Founded
- PGEN 1998
- QSI 2013
- Country
- PGEN United States
- QSI United States
- Employees
- PGEN N/A
- QSI N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- PGEN Health Care
- QSI Health Care
- Exchange
- PGEN Nasdaq
- QSI Nasdaq
- Market Cap
- PGEN 493.0M
- QSI 460.6M
- IPO Year
- PGEN N/A
- QSI N/A
- Fundamental
- Price
- PGEN $3.89
- QSI $1.58
- Analyst Decision
- PGEN Buy
- QSI Strong Buy
- Analyst Count
- PGEN 5
- QSI 3
- Target Price
- PGEN $7.50
- QSI $2.88
- AVG Volume (30 Days)
- PGEN 4.5M
- QSI 17.1M
- Earning Date
- PGEN 11-13-2025
- QSI 11-05-2025
- Dividend Yield
- PGEN N/A
- QSI N/A
- EPS Growth
- PGEN N/A
- QSI N/A
- EPS
- PGEN N/A
- QSI N/A
- Revenue
- PGEN $4,340,000.00
- QSI $3,177,000.00
- Revenue This Year
- PGEN $249.10
- QSI N/A
- Revenue Next Year
- PGEN $710.03
- QSI $219.33
- P/E Ratio
- PGEN N/A
- QSI N/A
- Revenue Growth
- PGEN N/A
- QSI 40.20
- 52 Week Low
- PGEN $0.65
- QSI $0.61
- 52 Week High
- PGEN $5.23
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- PGEN 49.47
- QSI 38.27
- Support Level
- PGEN $3.86
- QSI $2.02
- Resistance Level
- PGEN $4.35
- QSI $2.19
- Average True Range (ATR)
- PGEN 0.27
- QSI 0.18
- MACD
- PGEN -0.04
- QSI -0.10
- Stochastic Oscillator
- PGEN 23.33
- QSI 10.38
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.